Do you prefer the routine use of bivalirudin over UFH during PCI cases in patients presenting with ACS?   

The anti platelet strategy is the key, in terms of pre treatment, or post treatment, maintenance therapy or loading therapy, and choice of DAPT therapy….this anti platelet regimen in terms of timing of load and choice of non ASA anti platelet therapy, is a major factor in maximizing PCI outcomes. ...